Literature DB >> 21856271

Autophagy and hepatic stellate cell activation - partners in crime?

Christine C Hsu, Robert F Schwabe.   

Abstract

Mesh：

Year:  2011        PMID： 21856271     DOI： 10.1016/j.jhep.2011.08.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  New medical treatment strategies for nonalcoholic steatohepatitis.

Authors:  Michael Fuchs
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

Review 2.  Potential Therapeutic Targets and Promising Agents for Combating NAFLD.

Authors:  Atsushi Umemura; Seita Kataoka; Keiichiro Okuda; Yuya Seko; Kanji Yamaguchi; Michihisa Moriguchi; Takeshi Okanoue; Yoshito Itoh
Journal:  Biomedicines       Date:  2022-04-14

3.  Autophagy: A new therapeutic target for liver fibrosis.

Authors:  Yu-Qing Mao; Xiao-Ming Fan
Journal:  World J Hepatol       Date:  2015-08-08

4.  miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7.

Authors:  Kangkang Yu; Ning Li; Qi Cheng; Jianming Zheng; Mengqi Zhu; Suxia Bao; Mingquan Chen; Guangfeng Shi
Journal:  J Mol Med (Berl)       Date:  2017-10-19       Impact factor: 4.599

5.  Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.

Authors:  Seita Kataoka; Atsushi Umemura; Keiichiro Okuda; Hiroyoshi Taketani; Yuya Seko; Taichiro Nishikawa; Kanji Yamaguchi; Michihisa Moriguchi; Yoshihiro Kanbara; Jack L Arbiser; Toshihide Shima; Takeshi Okanoue; Yoshito Itoh
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.